Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
The offering involves 3,225,000 shares of common stock at $1.20 per share.
Gross proceeds are expected to be around $3.9 million before expenses.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before expenses.
Closure Date
Expected to be August 15, 2025, subject to customary closing conditions.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
- The offering is made pursuant to an effective shelf registration statement on Form S-3.
- The shares can only be offered through a prospectus supplement and accompanying prospectus.
Scienture Holdings, Inc. continues to focus on providing enhanced value through specialty pharmaceutical products.